Healthcare Venture Conference KYOTO 2020

2020開催概要図WEBUL.jpgOn Monday 19th October, Healthcare Venture Conference KYOTO 2020, which had been postponed due to COVID-19, was held in Kyoto Research Park. The event saw 350 participants in total including online participants. This year, 26 companies from 7 countries pitched, and 60 individual meetings have been arranged. In order to prevent COVID-19, we introduced onsite-online hybrid style. Guests and presenters located in Japan were invited to the venue, overseas speakers gave their presentations via Zoom, and YouTube Live was streamed for the other audience. We could not be more grateful for all the participants who came onboard in spite of the time difference or connection problems. Thank you!
Please take a look at our brief report below. The abstracts of the speeches will be posted when they are ready.

New information regarding the pitch and individual meeting for HVC KYOTO 2021 will be announced around February in 2021.
We look forward to your participation!

Date: 19th October 2020 9:30-18:20
Venue: B1F Bldg#4, Kyoto Research Park & ONLINE

Participant attributes by industry



9:30 Opening / Ichiro Sone, Executive Vice President, JETRO

9:35 Congratulatory / Dan Wang, MD, Head, Asia Pacific, J'J INNOVATION

9:40 Keynote Speech & Dialogue

Johannes Fruehauf, MD, PhD, Founder & CEO, LabCentral
Haruhiko Morita, President & CEO, Modalis Therapeutics Corp.
(Moderator: Tomoyoshi Koyanagi, PhD, Professor, University of Tsukuba)

10:35 Pitch Session1  5 on-site + 3 online, with open mentoring by 8 professionals

11:50 Lunch Break / Poster Session

12:50 Greetings Koji Murota, Head, Office of SACI, Kyoto University

13:00 Case Study, Special Lecture, & Dialogue

Mehrdad Shamloo, PhD, Director, Stanford University
Tomoyoshi Koyanagi, PhD, Professor, University of Tsukuba

14:05 Pitch Session2  4 on-site + 4 online, with open mentoring by 8 professionals

15:20 Pitch Session3  5 on-site + 3 online, with open mentoring by 8 professionals

16:35 Award Ceremony

17:00 UK Session

Karen Spink, PhD, Innovation lead Precision medicine, Innovate UK
Shirley Lam, PhD, Business Development Mgr. Asia, Cell and Gene Therapy CATAPULT
UK Start-up Pitch 2
QA Session (Moderator: Hirotaka Saso, Country Mgr., JAPAN, Cambridge Consultants)

18:00 Closing / Networking

HVC KYOTO 2020 Partners

・Japan External Trade Organization (JETRO) ・Kyoto Prefecture ・City of Kyoto

【Co-Organizer】 Kyoto University Office of Society Academia Collaboration for Innovation(SACI)
・The Kansai Bureau, Ministry of Economy, Trade and Industry(METI-KANSAI)
・Osaka Prefectural Government・Hyogo Prefectural Government・Osaka City Government・Kobe City Government
・The Osaka Chamber of Commerce and Industry  ・The Kyoto Chamber of Commerce and Industry
・The Kobe Chamber of Commerce and Industry ・Kyoto Industrial Support Organization 21
・Advanced Science, Technology & Management Research Institute of KYOTO(ASTEM)
・Foundation for Biomedical Research and Innovation at KOBE ・Urban Innovation Institute 
・Kyoto Industrial Association ・Kyoto Wisdom Industry Creation Center 
・Life Science Innovation Network Japan, Inc.(LINK-J)
・Kansai Health and Medical Association ・Kansai Health and Medical Care Innovation Council
・MIT Venture Forum of Japan(MIT-VFJ) ・Kansai Pharmaceutical Industries Association(KPIA)